Your browser doesn't support javascript.
loading
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors.
Stavraka, Chara; Pouptsis, Athanasios; Synowiec, Alicja; Angelis, Vasileios; Satterthwaite, Liyana; Khan, Sam; Chauhan, Meera; Holden, Chloe; Young, Sally; Karampera, Christina; Martinou, Maria; Mills-Baldock, Tina; Baxter, Mark; Barry, Ainsley; Eccles, Bryony; Iveson, Timothy; Shiu, Kai-Keen; Hill, Mark; Abdel-Raouf, Sherif; Graham, Janet Shirley; Thomas, Anne; Ross, Paul J.
Afiliación
  • Stavraka C; Department of Medical Oncology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom; School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, London, United Kingdom. Electronic address: chara.stavraka@kcl.ac.uk.
  • Pouptsis A; Department of Medical Oncology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Synowiec A; Kent Oncology Centre, Maidstone, United Kingdom.
  • Angelis V; Kent Oncology Centre, Maidstone, United Kingdom.
  • Satterthwaite L; Department of Medical Oncology, Southampton University Hospitals NHS Trust, Southampton, United Kingdom.
  • Khan S; Department of Medical Oncology, Leicester Royal Infirmary, Leicester, United Kingdom.
  • Chauhan M; Department of Medical Oncology, Leicester Royal Infirmary, Leicester, United Kingdom.
  • Holden C; Department of Medical Oncology, Poole hospital NHS Foundation Trust, Poole, United Kingdom.
  • Young S; Department of Medical Oncology, Poole hospital NHS Foundation Trust, Poole, United Kingdom.
  • Karampera C; Department of Medical Oncology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Martinou M; Department of Medical Oncology, Queen's Hospital, Essex, United Kingdom.
  • Mills-Baldock T; Department of Medical Oncology, Queen's Hospital, Essex, United Kingdom.
  • Baxter M; Department of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  • Barry A; Department of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  • Eccles B; Department of Medical Oncology, Poole hospital NHS Foundation Trust, Poole, United Kingdom.
  • Iveson T; University or Southampton, Southampton, United Kingdom.
  • Shiu KK; Department of Medical Oncology, University College London Hospital, London, United Kingdom.
  • Hill M; Kent Oncology Centre, Maidstone, United Kingdom.
  • Abdel-Raouf S; Department of Medical Oncology, Queen's Hospital, Essex, United Kingdom.
  • Graham JS; Department of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  • Thomas A; Leicester Cancer Research Centre, University of Leicester, Leicester, United Kingdom.
  • Ross PJ; Department of Medical Oncology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Clin Colorectal Cancer ; 20(4): 342-349, 2021 12.
Article en En | MEDLINE | ID: mdl-34696965

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Trifluridina Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Clin Colorectal Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Trifluridina Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Clin Colorectal Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article